MedPath

A study to understand role of calcarea carbonicum 200C to treat increased cholestrol.

Phase 3
Conditions
Health Condition 1: E781- Pure hyperglyceridemia
Registration Number
CTRI/2024/07/069704
Lead Sponsor
Sarada Krishna Homoeopathic Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients in between 30 – 60 years of age.

Both male and female.

Patients having triglyceride level 150 – 499 mg / dl.

Patient who has no history of any systemic illness.

Patient who are not under medication for Hypertriglyceridemia.

Patients willing to participate in the study.

Exclusion Criteria

Patient below 30 years and above 60 years.

Patient with history of cardiac complaint.

Patient with any known severe systemic illness (cancer, hepatic diseases, diabetes, any abnormality

in LFT and RFT).

Pregnant and lactating mothers.

Patient under medication for Hypertriglyceridemia.

Patients unable or unwilling to give informed consent.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
From this study the effectiveness of calcarea carbonica 200 in decreasing the triglycerides level will be known <br/ ><br>through pre and post lipid profile test with statistical analysis. <br/ ><br>Timepoint: 6 MONTHS
Secondary Outcome Measures
NameTimeMethod
ILTimepoint: NI
© Copyright 2025. All Rights Reserved by MedPath